Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

About the company

Tetraphase Pharmaceuticals, Inc. engages in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also engages in the development of product candidate, eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

67

CEO

Larry Edwards

Exchange

NASDAQ

Website

http://www.tphase.com

$8.00M

Total Revenue

67

Employees

$12.15M

Market Capitalization

-0.14

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$4M

Operating Margin (in %)

Total operating margin

$-62M

Net Margin (in %)

Total net margin

$-64M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12018.30 1376.00 5.12 18.95 43.06
Catalent, Inc. CTLT 11623.49 2872.00 5.84 111.44 3.63
Perrigo Co. Plc PRGO 7704.88 4837.00 1.32 52.56 3.02
Jazz Pharmaceuticals Plc JAZZ 6076.20 2188.00 2.10 22.21 12.81
Bausch Health Cos., Inc. BHC 6068.07 8597.00 8.47 -3.21 -21.96
United Therapeutics Corp. UTHR 5081.74 1443.00 1.76 9.81 36.59
MyoKardia, Inc. MYOK 4300.08 34.00 12.50 -13.87 -201.73
Axsome Therapeutics, Inc. AXSM 2906.40 None 19.72 -32.31 None
Pacira Biosciences, Inc. PCRX 2427.60 435.00 6.51 -5780.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2231.84 9.00 2.62 -3.45 -413.06
Corcept Therapeutics, Inc. CORT 2013.00 335.00 4.62 18.97 31.64
Prestige Consumer Healthcare, Inc. PBH 1863.54 963.00 1.57 13.14 14.77
Revolution Medicines, Inc. RVMD 1798.91 48.00 4.67 -25.41 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1558.65 0.00 4.16 -15.26 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1544.71 285.00 3.66 7.99 66.41
Intercept Pharmaceuticals, Inc. ICPT 1440.96 272.00 -42.89 -4.20 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1309.50 402.00 2.08 11.23 28.90
Theravance Biopharma, Inc. TBPH 1235.76 88.00 -8.67 -5.01 -280.80
Zogenix, Inc. ZGNX 1225.80 5.00 3.35 -2.88 -241.62
Revance Therapeutics, Inc. RVNC 1161.84 0.00 4.59 -6.23 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.66 327.00 2.49 19.56 15.90
Endo International Plc ENDP 784.32 3014.00 -1.07 -2.80 -9.09
BellRing Brands, Inc. BRBR 762.45 954.00 -0.41 5.78 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.30 192.00 3.65 269.17 1.29
Assembly Biosciences, Inc. ASMB 667.58 16.00 2.99 -6.71 -601.75
Aerie Pharmaceuticals, Inc. AERI 638.73 79.00 5.07 -3.16 -252.92
Intersect ENT, Inc. XENT 577.76 102.00 5.45 -11.57 -48.61
Collegium Pharmaceutical, Inc. COLL 577.66 299.00 4.13 -44.71 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 533.93 119.00 5.20 12.17 36.09
Anika Therapeutics, Inc. ANIK 494.90 125.00 1.71 17.85 22.73
BioDelivery Sciences International, Inc. BDSI 388.24 130.00 5.55 -52.75 -5.01
Albireo Pharma, Inc. ALBO 326.82 11.00 3.32 -4.28 -730.55
ANI Pharmaceuticals, Inc. ANIP 326.76 203.00 1.67 -209.46 -0.67
MEI Pharma, Inc. MEIP 275.56 5.00 4.74 -7.06 -539.48
Mallinckrodt Plc MNK 212.52 3037.00 0.11 -0.18 -39.56
Agile Therapeutics, Inc. AGRX 148.09 None 2.41 -7.17 None
Marinus Pharmaceuticals, Inc. MRNS 146.79 0.00 5.68 -2.18 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Zynerba Pharmaceuticals, Inc. ZYNE 85.79 0.00 1.41 -2.39 -699.94
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Evoke Pharma, Inc. EVOK 83.28 None 28.92 -12.39 None
Aclaris Therapeutics, Inc. ACRS 81.18 4.00 1.42 -0.59 None
Cassava Sciences, Inc. SAVA 76.66 41.00 4.03 -16.81 76.71
Adamas Pharmaceuticals, Inc. ADMS 75.32 57.00 -4.80 -0.81 -160.44
CTI BioPharma Corp. CTIC 71.98 3.00 3.21 -1.74 -111.83
Oramed Pharmaceuticals, Inc. ORMP 59.94 3.00 4.83 -4.69 -464.15
SCYNEXIS, Inc. SCYX 48.28 0.00 10.14 -1.25 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 47.70 47.00 0.97 -10.60 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 44.22 9.00 8.25 -13.20 -36.08
Lipocine, Inc. LPCN 40.20 0.00 9.57 -2.68 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 32.00 65.00 -2.46 -1.83 -26.74
PLx Pharma, Inc. PLXP 25.56 0.00 -2.45 -2.70 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.92 3.00 2.48 -1.68 -264.21
Regulus Therapeutics, Inc. RGLS 17.22 0.00 1.52 -0.80 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.15 8.00 0.64 -0.14 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.50 None 2.34 -0.63 None
Sonoma Pharmaceuticals, Inc. SNOA 6.44 19.00 1.02 -2.06 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.83 73.00 -0.13 -0.20 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 4.48 None 1.12 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Tetraphase Pharmaceuticals Inc.

6d ago, source: MarketWatch

11/04/2013 N/A S-1/A Registration Statement * 10/25/2013 N/A S-1 Registration Statement 06/14/2013 N/A S-8 Registration Statement 03/19/2013 N/A S-1/A Registration Statement * 03/05/2013 N/A S-1/A ...

Financials Tetraphase Pharmaceuticals

13d ago, source: Business Insider

Share Earnings Data (in USD) Tetraphase Pharmaceuticals Inc Registered Shs: Key Data (in USD) × Added To Watchlist ...

Tetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta

21d ago, source: Business Wire

Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline ...

La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.

19d ago, source: Business Wire

La Jolla Pharmaceutical Company, which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients ...

BRIEF-La Jolla Pharmaceutical Reports A Stake Of 14.9% In Tetraphase Pharmaceuticals Inc As Of June 15

20d ago, source: Reuters

LA JOLLA PHARMACEUTICAL CO REPORTS A STAKE OF 14.9% IN TETRAPHASE PHARMACEUTICALS INC AS OF JUNE 15 - SEC FILING * LA JOLLA PHARMACEUTICAL CO SAYS DOES NOT INTEND TO OBTAIN CONTROL OF TETRAPHASE ...

Tetraphase Pharmaceuticals Market Cap:

11d ago, source: YCharts

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a ...

La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer

21d ago, source: MSN

The bidding war for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) seems to be far from over. What Happened: Tetraphase announced Monday that La Jolla Pharmaceutical Company (NASDAQ: LJPC ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.